[Federal Register Volume 66, Number 16 (Wednesday, January 24, 2001)]
[Notices]
[Page 7654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-2108]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub.L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2:15 p.m., February 13, 2001. 8:30 a.m.-
2:45 p.m., February 14, 2001.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8:00 a.m. and 8:30 a.m. or 12:30 
p.m. and 1:00 p.m. Entrance to the meeting at other times during the 
day cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be Discussed: Agenda items will include: a report 
from the National Vaccine Program Office (NVPO) and the Interagency 
Vaccine Workgroup; a report on the cytomegalovirus vaccine (CMV) 
meeting; discussions on influenza vaccine supply and delay; pandemic 
influenza preparedness; NVAC Polio Containment Workgroup report; 
Vaccine Safety and Communication Subcommittee report; Immunization 
Coverage Subcommittee report; Future Vaccines Subcommittee report; 
update from the Office of the Assistant Secretary for Health and 
Surgeon General; a report on the Global Immunization Initiative; 
ACCV Annual Report, VRPBC Highlights, and ACIP Highlights; an update 
on the NVAC Mandatory Immunization Requirements Workgroup and a 
report of the Introduction of New Vaccines Workgroup.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2:15 p.m.-5 p.m., February 13, 2001.
    Place: Hubert H. Humphrey Building, Room 305A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters to be Discussed: Agenda items will include discussions 
on new National Institute of Health data on rotavirus and 
intussusception and future actions regarding CMV based on results of 
the National Vaccine Advisory Committee sponsored meeting.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2:15 p.m.-5 p.m., February 13, 2001.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters to be Discussed: Agenda items will include discussions 
on adult immunization standards; Pediatric immunization standards; 
an update on the Introduction of New Vaccines Workgroup; an update 
on the Mandatory Immunization Guidelines Workgroup; an update on 
Immunization Registries Progress Report; discussion of areas of 
focus for unmet needs funding; an update on the Strategies to 
Sustain Success Blue Ribbon Panel; and future dates for interim 
Subcommittee meetings.
    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 2:15 p.m.-5 p.m., February 13, 2001.
    Place: Hubert H. Humphrey Building, Room 325A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters to be Discussed: Review of the Executive Summary of the 
NVAC Risk Communication Workshop; a discussion of the Subcommittee's 
relationship with IOM; and, discussion of new business.

    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S D-66, 
Atlanta, Georgia 30333, telephone 404/687-6672.

    Dated: January 18, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-2108 Filed 1-23-01; 8:45 am]
BILLING CODE 4163-18-P